Article

T-helper cell derangements tied to atrial fibrillation in RA


 

Key clinical point: Elevated T helper (Th)1, Th17, or Th1/T-regulatory (Treg) cell frequencies in the peripheral blood were significantly associated with the development of atrial fibrillation (AF) in patients with rheumatoid arthritis (RA).

Major finding: The percentage of Th1 cells (adjusted odds ratio [aOR], 1.05; P = .0027], absolute number of Th17 cells (aOR, 1.11; P = .0046), and ratio of Th1/Treg (aOR, 1.08; P = .0374) were significantly associated with AF development in RA.

Study details: This was a retrospective case-control study of 40 patients with RA and AF who were propensity matched (1:3) with 120 control patients with RA.

Disclosures: This work was supported by the National Natural Science Foundation of China and the Excellent Youth Foundation of Shanxi Province. No conflict of interests was reported.

Source: Wang X et al. Front Immunol. 2021 Oct 15. doi: 10.3389/fimmu.2021.744254 .

Recommended Reading

Abatacept shows signal to delay onset of rheumatoid arthritis
MDedge Rheumatology
Statins’ effects on CVD outweigh risk for diabetes in RA
MDedge Rheumatology
When a JAK inhibitor fails for a patient with RA, what’s next?
MDedge Rheumatology
mRNA COVID vaccine response found mostly robust in RA, SLE patients
MDedge Rheumatology
Tofacitinib postmarketing trial data shed light on JAK inhibitor risks
MDedge Rheumatology
Long-term glucocorticoids in RA linked to increased cardiovascular risk
MDedge Rheumatology
Low-dose rituximab may keep RA disease activity low in responders
MDedge Rheumatology
No risk of increased flare after 2 doses of COVID-19 vaccination in RA
MDedge Rheumatology
RA: bDMARD monotherapy may accelerate radiographic progression of preexisting distal hand osteoarthritis
MDedge Rheumatology
Baricitinib demonstrates consistent long-term safety profile in RA
MDedge Rheumatology